Global /United States /Healthcare /Biotechnology /ZIVO
chevron_leftBack
ZIVO Bioscience, Inc. logo

ZIVO Bioscience, Inc.

ZIVO
OTCMKTS: ZIVO Delayed
3.43USD 66%
As of 13 June 2026, ZIVO Bioscience, Inc. has a market cap of $8.28M USD, ranking #42245 globally and #5433 in the United States. It ranks #3737 in the Healthcare sector, and #735 in the Biotechnology industry.
Global Rank
42245
Country Rank
5433
Sector Rank
3737
Industry Rank
735
Key Stats
Market Cap
$8.28MUSD
Enterprise Value
$9.05MUSD
Revenue (TTM)
$209.03KUSD
Net Income (TTM)
-$8.49MUSD
PS Ratio
39.6
PB Ratio
-2.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
John Payne open_in_new
Employees
7
Founded
1983
Website
zivobioscience.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
66% 127% -54% -67% -82% -84%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
ZIVO
Zivo Bioscience Inc
ISIN: US98978N3098
Shares Out.:
3.889M1 Shares Float: 1.662M2
TV:
SA:
YF:
GF:
BA:
MS:
3.43 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About ZIVO Bioscience, Inc.

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

Similar Companies

Industry: Biotechnology (United States)
Name
Market Cap diff.
PE
AMGN
$182.42B
2M%
23.9
GILD
$159.92B
2M%
19.0
NTRA
$27.6B
333K%
-
$26.3B
317K%
20.0
$25.03B
302K%
20.4
MRNA
$18.13B
219K%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
ARGX
$47.84B
41.39B EUR
577K%
39.9
$44.84B
68.19T KRW
541K%
35.5
CSL
$42.36B
60.27B AUD
511K%
29.3
LONN
$42.3B
33.71B CHF
511K%
37.2
068270
$28.11B
42.76T KRW
339K%
43.8
BNTX
$25.69B
310K%
-
chevron_leftBack